spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kukk, E.
Right arrow Articles by Alitalo, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kukk, E.
Right arrow Articles by Alitalo, K.
Breier, G., Albrecht, U., Sterrer, S. and Risau, W (1992). Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-532.[Abstract]

Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W. and Nagy, A (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.[Medline]

Dvorak, H. F., Brown, L. F., Detmar, M. and Dvorak, A. M (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am. J. Pathol 146, 1029-1039.[Abstract]

Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O\253Shea, K. S., Powell-Braxton, L., Hillan, K. J. and Moore, M. W (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.[Medline]

Folkman, J. and Shing, Y (1992). Angiogenesis. J. Biol. Chem 267, 10931-10934.[Free Full Text]

Hanahan, D. and Folkman, J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.[Medline]

Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. and Alitalo, K (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15, 290-298.[Medline]

Kaipainen, A., Korhonen, J., Pajusola, K., Aprelikova, O., Persico, M. G., Terman, B. I. and Alitalo, K (1993). The related FLT4, FLT1 and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med 178, 2077-2088.[Abstract/Free Full Text]

Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W. M., Fang, G.-H., Dumont, D., Breitman, M. and Alitalo, K (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566-3570.[Abstract/Free Full Text]

Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J. and Connolly, D. T (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.[Abstract/Free Full Text]

Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H. and Ferrara, N (1996). Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J. Biol. Chem 271, 5638-5646.[Abstract/Free Full Text]

Lee, J., Gray, A., Yuan, J., Luoh, S.-M., Avraham, H. and Wood, W. I (1996). Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. USA 93, 1988-1992.[Abstract/Free Full Text]

Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V. and Ferrara, N (1989). Vascular endothelial growth factor is secreted angiogenic mitogen. Science 246, 1306-1309.[Abstract/Free Full Text]

Morgenstern, J. P. and Land, H (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucl. Acids Res 18, 3587-3595.[Abstract/Free Full Text]

Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T. and Levi, B.-Z (1994). Vascular endothelial growth factor and its receptors. Progress in Growth Factor Res 5, 89-97.[Medline]

Oefner, C., D\253Arcy, A., Winkler, F. K., Eggimann, B. and Hosang, M (1992). Crystal structure of human platelet-derived growth factor BB. EMBO J 11, 3921-3926.[Medline]

Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V., Saksela, O., Orpana, A., Pettersson, R., Alitalo, K. and Eriksson, U (1996). Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. USA 93, 2576-2581.[Abstract/Free Full Text]

Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K. and Eriksson, U (1996). Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J. Biol. Chem 271, 19310-19317.[Abstract/Free Full Text]

Pajusola, K., Aprelikova, O., Pelicci, G., Weich, H., Claesson-Welsh, L.and Alitalo, K (1994). Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 9, 3545-3555.[Medline]

Pear, W. S., Nolan, G. P., Scott, M. L. and Baltimore, D (1994). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.[Abstract/Free Full Text]

Risau, W., Sariola, H., Zerwes, H.-G., Sasse, J., Ekblom, P., Kemler, R. and Doetschman, T (1988). Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102, 471-478.[Abstract]

Sabin, F. R (1909). The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. Am. J. Anat 9, 43-91.

Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L. and Schuh, A. C (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.[Medline]

Thomas, K. A (1996). Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem 271, 603-606.[Free Full Text]

von Heijne, G (1986). A new method for predicting signal sequence cleavage sites. Nucl. Acids Res 14, 4683-4691.[Abstract/Free Full Text]

V\212strik, I., Kaipainen, A., Penttil\212, T.-L., Lymboussakis, A., Alitalo, R., Parvinen, M. and Alitalo, K (1995). Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Biol 128, 1197-1208.[Abstract/Free Full Text]

Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. and Heldin, C.-H (1994). Different functional properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem 269, 26988-26995.[Abstract/Free Full Text]

Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L. and Rossant, J (1993). flk-1 , an flt -related tyrosine kinase is an early marker for endothelial cell precursors. Development 118, 489-498.[Abstract]




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
T. Sasaki, T. Nakamura, R. B. Rebhun, H. Cheng, K. S. Hale, R. Z. Tsan, I. J. Fidler, and R. R. Langley
Modification of the Primary Tumor Microenvironment by Transforming Growth Factor {alpha}-Epidermal Growth Factor Receptor Signaling Promotes Metastasis in an Orthotopic Colon Cancer Model
Am. J. Pathol., July 1, 2008; 173(1): 205 - 216.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
W. S. SHIN and S. G. ROCKSON
Animal Models for the Molecular and Mechanistic Study of Lymphatic Biology and Disease
Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 50 - 74.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. EL-CHEMALY, S. J. LEVINE, and J. MOSS
Lymphatics in Lung Disease
Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Sivakumar, N. Sharma-Walia, H. Raghu, M. V. Veettil, S. Sadagopan, V. Bottero, L. Varga, R. Levine, and B. Chandran
Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained Levels of Vascular Endothelial Growth Factors A and C Early during In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications
J. Virol., February 15, 2008; 82(4): 1759 - 1776.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. S. Sundar and T. S. Ganesan
Role of Lymphangiogenesis in Cancer
J. Clin. Oncol., September 20, 2007; 25(27): 4298 - 4307.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. J. Gaspar, L. Li, A. M. Kapoun, S. Medicherla, M. Reddy, G. Li, G. O'Young, D. Quon, M. Henson, D. L. Damm, et al.
Inhibition of Transforming Growth Factor beta Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness
Mol. Pharmacol., July 1, 2007; 72(1): 152 - 161.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Shayan, M. G. Achen, and S. A. Stacker
Lymphatic vessels in cancer metastasis: bridging the gaps
Carcinogenesis, September 1, 2006; 27(9): 1729 - 1738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Rutkowski, K. C. Boardman, and M. A. Swartz
Characterization of lymphangiogenesis in a model of adult skin regeneration
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1402 - H1410.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Favier, A. Alam, P. Barron, J. Bonnin, P. Laboudie, P. Fons, M. Mandron, J.-P. Herault, G. Neufeld, P. Savi, et al.
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration
Blood, August 15, 2006; 108(4): 1243 - 1250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Janer, P. Lassus, C. Haglund, K. Paavonen, K. Alitalo, and S. Andersson
Pulmonary Vascular Endothelial Growth Factor-C in Development and Lung Injury in Preterm Infants
Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 326 - 330.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. R. Foster, S. C. Satchell, J. Seckley, M. S. Emmett, K. Joory, C. Y. Xing, M. A. Saleem, P. W. Mathieson, D. O. Bates, and S. J. Harper
VEGF-C promotes survival in podocytes
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F196 - F207.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. M. Levine, A. Tulpule, D. I. Quinn, G. Gorospe III, D. L. Smith, L. Hornor, W. D. Boswell, B. M. Espina, S. G. Groshen, R. Masood, et al.
Phase I Study of Antisense Oligonucleotide Against Vascular Endothelial Growth Factor: Decrease in Plasma Vascular Endothelial Growth Factor With Potential Clinical Efficacy
J. Clin. Oncol., April 10, 2006; 24(11): 1712 - 1719.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
D. M. Sidle, J. Maddalozzo, J. D. Meier, M. Cornwell, V. Stellmach, and S. E. Crawford
Altered Pigment Epithelium-Derived Factor and Vascular Endothelial Growth Factor Levels in Lymphangioma Pathogenesis and Clinical Recurrence
Arch Otolaryngol Head Neck Surg, November 1, 2005; 131(11): 990 - 995.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.E. Ferguson III, R. W. Kelley, and C. Patterson
Mechanisms of Endothelial Differentiation in Embryonic Vasculogenesis
Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2246 - 2254.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. E. Baldwin, M. M. Halford, S. Roufail, R. A. Williams, M. L. Hibbs, D. Grail, H. Kubo, S. A. Stacker, and M. G. Achen
Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
Mol. Cell. Biol., March 15, 2005; 25(6): 2441 - 2449.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen
The biology of vascular endothelial growth factors
Cardiovasc Res, February 15, 2005; 65(3): 550 - 563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Sipos, W. Klapper, M.-L. Kruse, H. Kalthoff, D. Kerjaschki, and G. Kloppel
Expression of Lymphangiogenic Factors and Evidence of Intratumoral Lymphangiogenesis in Pancreatic Endocrine Tumors
Am. J. Pathol., October 1, 2004; 165(4): 1187 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Fukasawa and M. Korc
Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines
Clin. Cancer Res., May 15, 2004; 10(10): 3327 - 3332.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
P. SAHARINEN and T. V. PETROVA
Molecular Regulation of Lymphangiogenesis
Ann. N.Y. Acad. Sci., April 1, 2004; 1014(1): 76 - 87.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. R. Dana
Corneal Antigen-Presenting Cells: Diversity, Plasticity, and Disguise The Cogan Lecture
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 722 - 727.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
F Belgore, A Blann, D Neil, A S Ahmed, and G Y H Lip
Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries
J. Clin. Pathol., March 1, 2004; 57(3): 266 - 272.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
J. J. Homer, M. G. Prentice, L. Cawkwell, M. Birchall, J. Greenman, and N. D. Stafford
Angiogenesis and the Expression of Vascular Endothelial Growth Factors A and C in Squamous Cell Carcinoma of the Piriform Fossa
Arch Otolaryngol Head Neck Surg, October 1, 2003; 129(10): 1110 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Hamrah, L. Chen, Q. Zhang, and M. R. Dana
Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells
Am. J. Pathol., July 1, 2003; 163(1): 57 - 68.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Matsumura, M. Hirashima, M. Ogawa, H. Kubo, H. Hisatsune, N. Kondo, S. Nishikawa, T. Chiba, and S.-I. Nishikawa
Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3
Blood, February 15, 2003; 101(4): 1367 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. E. FERRELL
Research Perspectives in Inherited Lymphatic Disease
Ann. N.Y. Acad. Sci., December 1, 2002; 979(1): 39 - 51.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. A. STACKER, M. E. BALDWIN, and M. G. ACHEN
The role of tumor lymphangiogenesis in metastatic spread
FASEB J, July 1, 2002; 16(9): 922 - 934.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. Jussila and K. Alitalo
Vascular Growth Factors and Lymphangiogenesis
Physiol Rev, July 1, 2002; 82(3): 673 - 700.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
Y. He, K.-i. Kozaki, T. Karpanen, K. Koshikawa, S. Yla-Herttuala, T. Takahashi, and K. Alitalo
Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling
J Natl Cancer Inst, June 5, 2002; 94(11): 819 - 825.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. V. Byzova, C. K. Goldman, J. Jankau, J. Chen, G. Cabrera, M. G. Achen, S. A. Stacker, K. A. Carnevale, M. Siemionow, S. R. Deitcher, et al.
Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo
Blood, May 29, 2002; 99(12): 4434 - 4442.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. Oliver and M. Detmar
The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature
Genes & Dev., April 1, 2002; 16(7): 773 - 783.
[Full Text] [PDF]


Home page
BloodHome page
S. Dias, M. Choy, K. Alitalo, and S. Rafii
Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy
Blood, March 15, 2002; 99(6): 2179 - 2184.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
T. Matsumoto and L. Claesson-Welsh
VEGF Receptor Signal Transduction
Sci. Signal., December 11, 2001; 2001(112): re21 - re21.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. F. Wang, X.-F. Zhang, and J. E. Groopman
Stimulation of beta 1 Integrin Induces Tyrosine Phosphorylation of Vascular Endothelial Growth Factor Receptor-3 and Modulates Cell Migration
J. Biol. Chem., November 2, 2001; 276(45): 41950 - 41957.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
R. P Erickson, S. L Dagenais, M. S Caulder, C. A Downs, G. Herman, M. C Jones, W. S Kerstjens-Frederikse, A. C Lidral, M. McDonald, C. C Nelson, et al.
Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations
J. Med. Genet., November 1, 2001; 38(11): 761 - 766.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. Clarijs, L. Schalkwijk, D. J. Ruiter, and R. M. W. de Waal
Lack of Lymphangiogenesis Despite Coexpression of VEGF-C and Its Receptor Flt-4 in Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1422 - 1428.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
X. F. Li, D. S. Charnock-Jones, E. Zhang, S. Hiby, S. Malik, K. Day, D. Licence, J. M. Bowen, L. Gardner, A. King, et al.
Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1823 - 1834.
[Abstract] [Full Text]


Home page
FASEB J.Home page
K. ILJIN, M. J. KARKKAINEN, E. C. LAWRENCE, M. A. KIMAK, M. UUTELA, J. TAIPALE KATRI PAJUSOLA LEENA ALHONEN, M. HALMEKYTO, D. N. FINEGOLD, R. E. FERRELL, and K. ALITALO
VEGFR3 gene structure, regulatory region, and sequence polymorphisms
FASEB J, April 1, 2001; 15(6): 1028 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Karpanen, M. Egeblad, M. J. Karkkainen, H. Kubo, S. Ylä-Herttuala, M. Jäättelä, and K. Alitalo
Vascular Endothelial Growth Factor C Promotes Tumor Lymphangiogenesis and Intralymphatic Tumor Growth
Cancer Res., March 1, 2001; 61(5): 1786 - 1790.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
W. J. Huss, C. F. Hanrahan, R. J. Barrios, J. W. Simons, and N. M. Greenberg
Angiogenesis and Prostate Cancer: Identification of A Molecular Progression Switch
Cancer Res., March 1, 2001; 61(6): 2736 - 2743.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
M. S. Pepper
Lymphangiogenesis and Tumor Metastasis: Myth or Reality?
Clin. Cancer Res., March 1, 2001; 7(3): 462 - 468.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
I. Zachary and G. Gliki
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
Cardiovasc Res, February 16, 2001; 49(3): 568 - 581.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Robinson and S. Stringer
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
J. Cell Sci., January 3, 2001; 114(5): 853 - 865.
[Abstract] [PDF]


Home page
ASH Education BookHome page
R. J. Klasa, A. F. List, and B. D. Cheson
Rational Approaches to Design of Therapeutics Targeting Molecular Markers
Hematology, January 1, 2001; 2001(1): 443 - 462.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Hamada, Y. Oike, N. Takakura, Y. Ito, L. Jussila, D. J. Dumont, K. Alitalo, and T. Suda
VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis
Blood, December 1, 2000; 96(12): 3793 - 3800.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. P. Gunningham, M. J. Currie, C. Han, B. A. Robinson, P. A. E. Scott, A. L. Harris, and S. B. Fox
The Short Form of the Alternatively Spliced flt-4 but not Its Ligand Vascular Endothelial Growth Factor C Is Related to Lymph Node Metastasis in Human Breast Cancers
Clin. Cancer Res., November 1, 2000; 6(11): 4278 - 4286.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. A. PARTANEN, J. AROLA, A. SAARISTO, L. JUSSILA, A. ORA, M. MIETTINEN, S. A. STACKER, M. G. ACHEN, and K. ALITALO
VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues
FASEB J, October 1, 2000; 14(13): 2087 - 2096.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
A. Saaristo, T. A. Partanen, J. Arola, L. Jussila, M. Hytonen, A. Makitie, S. Vento, A. Kaipainen, H. Malmberg, and K. Alitalo
Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in the Nasal Mucosa and in Nasopharyngeal Tumors
Am. J. Pathol., July 1, 2000; 157(1): 7 - 14.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Niki, S. Iba, M. Tokunou, T. Yamada, Y. Matsuno, and S. Hirohashi
Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma
Clin. Cancer Res., June 1, 2000; 6(6): 2431 - 2439.
[Abstract] [Full Text]


Home page
Ann. N. Y. Acad. Sci.Home page
P. CARMELIET and D. COLLEN
Molecular Basis of Angiogenesis: Role of VEGF and VE-Cadherin
Ann. N.Y. Acad. Sci., May 1, 2000; 902(1): 249 - 264.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. M. L. Deckers, M. Karperien, C. van der Bent, T. Yamashita, S. E. Papapoulos, and C. W. G. M. Lowik
Expression of Vascular Endothelial Growth Factors and Their Receptors during Osteoblast Differentiation
Endocrinology, May 1, 2000; 141(5): 1667 - 1674.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
S. D. Nathanson, R. J. Zarbo, D. L. Wachna, C. A. Spence, T. A. Andrzejewski, and J. Abrams
Microvessels That Predict Axillary Lymph Node Metastases in Patients With Breast Cancer
Arch Surg, May 1, 2000; 135(5): 586 - 594.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Paavonen, P. Puolakkainen, L. Jussila, T. Jahkola, and K. Alitalo
Vascular Endothelial Growth Factor Receptor-3 in Lymphangiogenesis in Wound Healing
Am. J. Pathol., May 1, 2000; 156(5): 1499 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Wood, G. Bold, E. Buchdunger, R. Cozens, S. Ferrari, J. Frei, F. Hofmann, J. Mestan, H. Mett, T. O’Reilly, et al.
PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration
Cancer Res., April 1, 2000; 60(8): 2178 - 2189.
[Abstract] [Full Text]


Home page
BloodHome page
V. L. Bautch, S. D. Redick, A. Scalia, M. Harmaty, P. Carmeliet, and R. Rapoport
Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A
Blood, March 15, 2000; 95(6): 1979 - 1987.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Lymboussaki, B. Olofsson, U. Eriksson, and K. Alitalo
Vascular Endothelial Growth Factor (VEGF) and VEGF-C Show Overlapping Binding Sites in Embryonic Endothelia and Distinct Sites in Differentiated Adult Endothelia
Circ. Res., November 26, 1999; 85(11): 992 - 999.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Marchio, L. Primo, M. Pagano, G. Palestro, A. Albini, T. Veikkola, I. Cascone, K. Alitalo, and F. Bussolino
Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi's Sarcoma Cells
J. Biol. Chem., September 24, 1999; 274(39): 27617 - 27622.
[Abstract] [Full